Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVolitionRX Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.83 | -$0.63 | -$0.73 |
| Q2 2026 | 2 | -$0.81 | -$0.61 | -$0.71 |
| Q3 2026 | 1 | -$0.68 | -$0.59 | -$0.64 |
| Q4 2026 | 1 | -$0.55 | -$0.47 | -$0.51 |
| Q1 2027 | 1 | $7.13 | $8.23 | $7.69 |
| Q2 2027 | 1 | $7.09 | $8.18 | $7.65 |
| Q3 2027 | 1 | $7.21 | $8.32 | $7.78 |
| Q4 2027 | 1 | $7.68 | $8.87 | $8.29 |
| Q1 2028 | 1 | $9.64 | $11.13 | $10.41 |
| Q2 2028 | 1 | $9.60 | $11.08 | $10.36 |
| Q3 2028 | 1 | $9.78 | $11.29 | $10.55 |
| Q4 2028 | 1 | $10.41 | $12.01 | $11.23 |
VolitionRX Ltd Earnings Date And Information
VolitionRX Ltd last posted its earnings results on Tuesday, March 31st, 2026. The company reported $-1 earnings per share for the quarter, missing analysts' consensus estimates of $-0.73 by $0.27. The company had revenue of 447.03 K for the quarter and had revenue of 1.73 M for the year. VolitionRX Ltd has generated $-4 earnings per share over the last year ($-4.4 diluted earnings per share) and currently has a price-to-earnings ratio of -0.53. VolitionRX Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
VolitionRX Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 2025 | -$0.73 | -$1.05 | -0.32 | $753.58 K | $447.03 K |
| 11/13/2025 | Q3 2025 | -$0.04 | -$1.00 | -0.96 | $1.68 M | $627.28 K |
| 08/14/2025 | Q2 2025 | -$0.05 | -$1.22 | -1.17 | $417.20 K | $406.69 K |
| 05/15/2025 | Q1 2025 | -$0.06 | -$1.12 | -1.06 | $917.13 K | $246.39 K |
| 03/31/2025 | Q4 2024 | -$0.06 | -$1.32 | -1.26 | $659.00 K | $191.66 K |
| 11/14/2024 | Q3 2024 | -$0.07 | -$1.32 | -1.25 | $652.00 K | $474.52 K |
| 08/14/2024 | Q2 2024 | -$0.09 | -$1.69 | -1.6 | $462.98 K | $395.80 K |
| 05/13/2024 | Q1 2024 | -$0.11 | -$2.00 | -1.89 | N/A | $171.54 K |
| 03/25/2024 | Q4 2023 | N/A | -$2.20 | N/A | N/A | $243.97 K |
| 11/14/2023 | Q3 2023 | -$0.12 | -$2.20 | -2.08 | N/A | $165.21 K |
| 08/14/2023 | Q2 2023 | N/A | -$2.80 | N/A | N/A | $216.31 K |
| 05/10/2023 | Q1 2023 | N/A | -$3.00 | N/A | N/A | $149.81 K |
| 03/15/2023 | Q4 2022 | -$0.15 | -$2.60 | -2.45 | N/A | $119.72 K |
| 11/14/2022 | Q3 2022 | -$0.15 | -$2.80 | -2.65 | N/A | $32.71 K |
| 08/10/2022 | Q2 2022 | -$0.15 | -$2.80 | -2.65 | N/A | $39.75 K |
| 05/11/2022 | Q1 2022 | $0.04 | -$2.80 | -2.84 | N/A | $114.21 K |
| 03/30/2022 | Q4 2021 | -$0.14 | -$3.00 | -2.86 | N/A | $14.24 K |
| 11/10/2021 | Q3 2021 | -$0.10 | -$2.60 | -2.5 | N/A | $25.48 K |
| 08/11/2021 | Q2 2021 | -$0.12 | -$2.00 | -1.88 | N/A | $24.78 K |
| 05/11/2021 | Q1 2021 | -$0.12 | -$2.40 | -2.28 | N/A | $25.53 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
VolitionRX Ltd Earnings: FAQ's
The conference call for VolitionRX Ltd's latest earnings report can be listened to online.
The conference call transcript for VolitionRX Ltd's latest earnings report can be read online.
VolitionRX Ltd (:VNRX) has a recorded annual revenue of $1.73 M.
VolitionRX Ltd (:VNRX) has a recorded net income of $-23,357,027.VolitionRX Ltd has generated $-4.4 earnings per share over the last four quarters.
VolitionRX Ltd (:VNRX) has a price-to-earnings ratio of -0.53 and price/earnings-to-growth ratio is -0.01.